Developed by Pfizer, Abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
HIFU is a state-of-the-art treatment that utilizes high-frequency sound waves to target and destroy prostate cancer cells
US FDA approval based on NEURO-TTRansform Phase III results
First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
Subscribe To Our Newsletter & Stay Updated
